Cargando…

2018 consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the diagnosis and treatment of cancer of unknown primary

Cancer of unknown primary (CUP) is defined as a heterogeneous group of tumours that present with metastasis, and in which attempts to identify the original site have failed. They differ from other primary tumours in their biological features and how they spread, which means that they can be consider...

Descripción completa

Detalles Bibliográficos
Autores principales: Losa, F., Iglesias, L., Pané, M., Sanz, J., Nieto, B., Fusté, V., de la Cruz-Merino, L., Concha, Á., Balañá, C., Matías-Guiu, X.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182632/
https://www.ncbi.nlm.nih.gov/pubmed/29808414
http://dx.doi.org/10.1007/s12094-018-1899-z
_version_ 1783362610720145408
author Losa, F.
Iglesias, L.
Pané, M.
Sanz, J.
Nieto, B.
Fusté, V.
de la Cruz-Merino, L.
Concha, Á.
Balañá, C.
Matías-Guiu, X.
author_facet Losa, F.
Iglesias, L.
Pané, M.
Sanz, J.
Nieto, B.
Fusté, V.
de la Cruz-Merino, L.
Concha, Á.
Balañá, C.
Matías-Guiu, X.
author_sort Losa, F.
collection PubMed
description Cancer of unknown primary (CUP) is defined as a heterogeneous group of tumours that present with metastasis, and in which attempts to identify the original site have failed. They differ from other primary tumours in their biological features and how they spread, which means that they can be considered a separate entity. There are several hypotheses regarding their origin, but the most plausible explanation for their aggressiveness and chemoresistance seems to involve chromosomal instability. Depending on the type of study done, CUP can account for 2–9% of all cancer patients, mostly 60–75 years old. This article reviews the main clinical, pathological, and molecular studies conducted to analyse and determine the origin of CUP. The main strategies for patient management and treatment, by both clinicians and pathologists, are also addressed.
format Online
Article
Text
id pubmed-6182632
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-61826322018-10-24 2018 consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the diagnosis and treatment of cancer of unknown primary Losa, F. Iglesias, L. Pané, M. Sanz, J. Nieto, B. Fusté, V. de la Cruz-Merino, L. Concha, Á. Balañá, C. Matías-Guiu, X. Clin Transl Oncol Review Article Cancer of unknown primary (CUP) is defined as a heterogeneous group of tumours that present with metastasis, and in which attempts to identify the original site have failed. They differ from other primary tumours in their biological features and how they spread, which means that they can be considered a separate entity. There are several hypotheses regarding their origin, but the most plausible explanation for their aggressiveness and chemoresistance seems to involve chromosomal instability. Depending on the type of study done, CUP can account for 2–9% of all cancer patients, mostly 60–75 years old. This article reviews the main clinical, pathological, and molecular studies conducted to analyse and determine the origin of CUP. The main strategies for patient management and treatment, by both clinicians and pathologists, are also addressed. Springer International Publishing 2018-05-28 2018 /pmc/articles/PMC6182632/ /pubmed/29808414 http://dx.doi.org/10.1007/s12094-018-1899-z Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Review Article
Losa, F.
Iglesias, L.
Pané, M.
Sanz, J.
Nieto, B.
Fusté, V.
de la Cruz-Merino, L.
Concha, Á.
Balañá, C.
Matías-Guiu, X.
2018 consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the diagnosis and treatment of cancer of unknown primary
title 2018 consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the diagnosis and treatment of cancer of unknown primary
title_full 2018 consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the diagnosis and treatment of cancer of unknown primary
title_fullStr 2018 consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the diagnosis and treatment of cancer of unknown primary
title_full_unstemmed 2018 consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the diagnosis and treatment of cancer of unknown primary
title_short 2018 consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the diagnosis and treatment of cancer of unknown primary
title_sort 2018 consensus statement by the spanish society of pathology and the spanish society of medical oncology on the diagnosis and treatment of cancer of unknown primary
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182632/
https://www.ncbi.nlm.nih.gov/pubmed/29808414
http://dx.doi.org/10.1007/s12094-018-1899-z
work_keys_str_mv AT losaf 2018consensusstatementbythespanishsocietyofpathologyandthespanishsocietyofmedicaloncologyonthediagnosisandtreatmentofcancerofunknownprimary
AT iglesiasl 2018consensusstatementbythespanishsocietyofpathologyandthespanishsocietyofmedicaloncologyonthediagnosisandtreatmentofcancerofunknownprimary
AT panem 2018consensusstatementbythespanishsocietyofpathologyandthespanishsocietyofmedicaloncologyonthediagnosisandtreatmentofcancerofunknownprimary
AT sanzj 2018consensusstatementbythespanishsocietyofpathologyandthespanishsocietyofmedicaloncologyonthediagnosisandtreatmentofcancerofunknownprimary
AT nietob 2018consensusstatementbythespanishsocietyofpathologyandthespanishsocietyofmedicaloncologyonthediagnosisandtreatmentofcancerofunknownprimary
AT fustev 2018consensusstatementbythespanishsocietyofpathologyandthespanishsocietyofmedicaloncologyonthediagnosisandtreatmentofcancerofunknownprimary
AT delacruzmerinol 2018consensusstatementbythespanishsocietyofpathologyandthespanishsocietyofmedicaloncologyonthediagnosisandtreatmentofcancerofunknownprimary
AT conchaa 2018consensusstatementbythespanishsocietyofpathologyandthespanishsocietyofmedicaloncologyonthediagnosisandtreatmentofcancerofunknownprimary
AT balanac 2018consensusstatementbythespanishsocietyofpathologyandthespanishsocietyofmedicaloncologyonthediagnosisandtreatmentofcancerofunknownprimary
AT matiasguiux 2018consensusstatementbythespanishsocietyofpathologyandthespanishsocietyofmedicaloncologyonthediagnosisandtreatmentofcancerofunknownprimary